Product Information
NICARDIPINE 30 MG CAPSULE is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $3.9440 per EA under NDC 68462012190. Its NADAC has been published 83 times since Dec 18, 2024.
FDA first approved this application on Dec 16, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462012190
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
7/23/2025
Active Ingredients
NICARDIPINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA216357FDA Approved
12/16/2022
TE Code
AB
On Market Since
12/16/2022
Pharmacological Classes
Price Statistics
The NADAC for NICARDIPINE 30 MG CAPSULE has been published 83 times since Dec 18, 2024, and over the history we have for it it has risen 19.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.9440 per EA |
|---|---|
| All-time high | $3.9440 (Jul 15, 2026) |
| All-time low | $3.3006 (Jan 22, 2025) |
| 52-week high | $3.9440 |
| 52-week low | $3.9440 |
| Median price | $3.9440 |
| Average price | $3.8057 |
| Largest weekly change | +6.0% (Apr 23, 2025) |
| Weeks tracked | 83 |
| Tracking since | Dec 18, 2024 |
1W
N/A
1M
N/A
3M
0.0%
6M
0.0%
1Y
0.0%
3Y
N/A
5Y
N/A
All
+19.4%
Last surveyed Jul 15, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 41% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of NICARDIPINE 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for NICARDIPINE 30 MG CAPSULE, manufactured by Glenmark Pharmaceuticals Inc., USA, is $3.9440 per EA (NDC 68462012190), effective Jul 15, 2026.
How has the price of NICARDIPINE 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for NICARDIPINE 30 MG CAPSULE has risen 19.4%. It has been tracked across 83 weekly CMS publications since Dec 18, 2024.
What are the highest and lowest recorded NADAC prices for NICARDIPINE 30 MG CAPSULE?
Since Dec 18, 2024, the NADAC for NICARDIPINE 30 MG CAPSULE has ranged from a low of $3.3006 (Jan 22, 2025) to a high of $3.9440 (Jul 15, 2026), with a median of $3.9440 per EA.
Are there cheaper alternatives to NICARDIPINE 30 MG CAPSULE?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NICARDIPINE 30 MG CAPSULE, is $2.3128 per EA — about 41% below NICARDIPINE 30 MG CAPSULE.
Who manufactures NICARDIPINE 30 MG CAPSULE?
NICARDIPINE 30 MG CAPSULE (NDC 68462012190) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.